Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022 May;33(3):e41.
doi: 10.3802/jgo.2022.33.e41. Epub 2022 Feb 21.

Posterior pelvic exenteration, a crucial component in the surgeon's toolbox for optimizing surgical cytoreduction for advanced ovarian cancer

Lea A Moukarzel  1 , Dennis S Chi  2
Affiliations
Editorial

Posterior pelvic exenteration, a crucial component in the surgeon's toolbox for optimizing surgical cytoreduction for advanced ovarian cancer

Lea A Moukarzel et al. J Gynecol Oncol. 2022 May.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Outside the submitted work, Dr. Chi reports personal fees from Apyx Medical Corp., Biom 'Up and AstraZeneca, as well as stock/options of Doximity, Moderna, BioNTech SE, and Apyx Medical Corp.

Comment on

Similar articles

See all similar articles

Cited by

References

    1. Houvenaeghel G, de Nonneville A, Blache G, Buttarelli M, Jauffret C, Mokart D, et al. Posterior pelvic exenteration for ovarian cancer: surgical and oncological outcomes. J Gynecol Oncol. 2022;33:e31. - PMC - PubMed
    1. Tseng JH, Cowan RA, Zhou Q, Iasonos A, Byrne M, Polcino T, et al. Continuous improvement in primary debulking surgery for advanced ovarian cancer: Do increased complete gross resection rates independently lead to increased progression-free and overall survival? Gynecol Oncol. 2018;151:24–31. - PMC - PubMed
    1. Wallace S, Kumar A, Mc Gree M, Weaver A, Mariani A, Langstraat C, et al. Efforts at maximal cytoreduction improve survival in ovarian cancer patients, even when complete gross resection is not feasible. Gynecol Oncol. 2017;145:21–26. - PubMed
    1. Tseng JH, Suidan RS, Zivanovic O, Gardner GJ, Sonoda Y, Levine DA, et al. Diverting ileostomy during primary debulking surgery for ovarian cancer: associated factors and postoperative outcomes. Gynecol Oncol. 2016;142:217–224. - PMC - PubMed
    1. Peiretti M, Bristow RE, Zapardiel I, Gerardi M, Zanagnolo V, Biffi R, et al. Rectosigmoid resection at the time of primary cytoreduction for advanced ovarian cancer. A multi-center analysis of surgical and oncological outcomes. Gynecol Oncol. 2012;126:220–223. - PubMed